GLENMARK LIFE SCIENCES
|
GLENMARK LIFE SCIENCES Last 5 Year Income Statement History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
INCOME : | |||||
Gross Sales | ₹2,173 Cr | ₹2,126 Cr | ₹1,890 Cr | ₹1,539 Cr | ₹886 Cr |
Sales | ₹2,059 Cr | ₹2,090 Cr | ₹1,866 Cr | ₹1,496 Cr | ₹852 Cr |
Job Work/ Contract Receipts | - | - | - | - | - |
Processing Charges / Service Income | - | - | - | - | - |
Revenue from property development | - | - | - | - | - |
Other Operational Income | ₹113 Cr | ₹36 Cr | ₹24 Cr | ₹43 Cr | ₹34 Cr |
Less: Excise Duty | - | - | - | - | - |
Net Sales | ₹2,161 Cr | ₹2,123 Cr | ₹1,885 Cr | ₹1,537 Cr | ₹886 Cr |
EXPENDITURE : | |||||
Increase/Decrease in Stock | ₹-84 Cr | ₹41 Cr | ₹-71 Cr | ₹-4.64 Cr | ₹-302 Cr |
Raw Material Consumed | ₹1,069 Cr | ₹978 Cr | ₹948 Cr | ₹669 Cr | ₹634 Cr |
Opening Raw Materials | ₹165 Cr | ₹117 Cr | ₹86 Cr | ₹80 Cr | - |
Purchases Raw Materials | ₹1,072 Cr | ₹1,026 Cr | ₹979 Cr | ₹675 Cr | ₹714 Cr |
Closing Raw Materials | ₹168 Cr | ₹165 Cr | ₹117 Cr | ₹86 Cr | ₹80 Cr |
Other Direct Purchases / Brought in cost | - | - | - | - | - |
Other raw material cost | - | - | - | - | - |
Power & Fuel Cost | ₹116 Cr | ₹101 Cr | ₹74 Cr | ₹77 Cr | ₹58 Cr |
Electricity & Power | ₹116 Cr | ₹101 Cr | ₹74 Cr | ₹77 Cr | ₹58 Cr |
Oil, Fuel & Natural gas | - | - | - | - | - |
Coals etc | - | - | - | - | - |
Other power & fuel | - | - | - | - | - |
Employee Cost | ₹180 Cr | ₹169 Cr | ₹149 Cr | ₹142 Cr | ₹106 Cr |
Salaries, Wages & Bonus | ₹165 Cr | ₹155 Cr | ₹139 Cr | ₹133 Cr | ₹99 Cr |
Contributions to EPF & Pension Funds | ₹11 Cr | ₹9.66 Cr | ₹9.50 Cr | ₹7.92 Cr | ₹5.89 Cr |
Workmen and Staff Welfare Expenses | ₹1.32 Cr | ₹0.93 Cr | ₹0.67 Cr | ₹1.26 Cr | ₹1.60 Cr |
Other Employees Cost | ₹3.19 Cr | ₹3.50 Cr | - | - | - |
Other Manufacturing Expenses | ₹137 Cr | ₹124 Cr | ₹108 Cr | ₹108 Cr | ₹77 Cr |
Sub-contracted / Out sourced services | - | - | - | - | - |
Processing Charges | ₹57 Cr | ₹61 Cr | ₹40 Cr | ₹43 Cr | ₹25 Cr |
Repairs and Maintenance | ₹33 Cr | ₹25 Cr | ₹29 Cr | ₹26 Cr | ₹23 Cr |
Packing Material Consumed | - | - | - | - | - |
Other Mfg Exp | ₹47 Cr | ₹38 Cr | ₹39 Cr | ₹39 Cr | ₹30 Cr |
General and Administration Expenses | ₹46 Cr | ₹54 Cr | ₹43 Cr | ₹44 Cr | ₹30 Cr |
Rent , Rates & Taxes | ₹4.49 Cr | ₹2.84 Cr | ₹2.36 Cr | ₹2.29 Cr | ₹2.88 Cr |
Insurance | ₹4.26 Cr | ₹3.44 Cr | ₹3.31 Cr | ₹3.32 Cr | ₹0.30 Cr |
Printing and stationery | - | - | - | - | - |
Professional and legal fees | ₹3.53 Cr | ₹3.68 Cr | ₹3.55 Cr | ₹3.42 Cr | ₹8.07 Cr |
Traveling and conveyance | ₹6.73 Cr | ₹5.42 Cr | ₹4.56 Cr | ₹6.27 Cr | ₹5.05 Cr |
Other Administration | ₹27 Cr | ₹39 Cr | ₹30 Cr | ₹29 Cr | ₹13 Cr |
Selling and Distribution Expenses | ₹45 Cr | ₹32 Cr | ₹34 Cr | ₹26 Cr | ₹28 Cr |
Advertisement & Sales Promotion | ₹9.48 Cr | ₹5.94 Cr | ₹7.03 Cr | ₹14 Cr | ₹9.55 Cr |
Sales Commissions & Incentives | ₹20 Cr | ₹8.95 Cr | ₹13 Cr | ₹3.16 Cr | ₹3.35 Cr |
Freight and Forwarding | ₹15 Cr | ₹17 Cr | ₹14 Cr | ₹9.53 Cr | ₹15 Cr |
Handling and Clearing Charges | - | - | - | - | - |
Other Selling Expenses | - | - | - | - | - |
Miscellaneous Expenses | ₹10 Cr | ₹8.23 Cr | ₹8.54 Cr | ₹3.86 Cr | ₹8.53 Cr |
Bad debts /advances written off | - | - | - | - | - |
Provision for doubtful debts | - | - | - | - | - |
Losson disposal of fixed assets(net) | ₹0.56 Cr | ₹0.74 Cr | ₹0.58 Cr | ₹1.23 Cr | ₹0.63 Cr |
Losson foreign exchange fluctuations | - | - | ₹3.46 Cr | - | ₹6.72 Cr |
Losson sale of non-trade current investments | - | - | - | - | - |
Other Miscellaneous Expenses | ₹9.74 Cr | ₹7.49 Cr | ₹4.50 Cr | ₹2.63 Cr | ₹1.18 Cr |
Less: Expenses Capitalised | - | - | - | - | - |
Total Expenditure | ₹1,519 Cr | ₹1,507 Cr | ₹1,294 Cr | ₹1,065 Cr | ₹639 Cr |
Operating Profit (Excl OI) | ₹642 Cr | ₹616 Cr | ₹591 Cr | ₹472 Cr | ₹247 Cr |
Other Income | ₹29 Cr | ₹15 Cr | ₹0.81 Cr | ₹12 Cr | ₹0.99 Cr |
Interest Received | ₹16 Cr | ₹6.78 Cr | ₹0.43 Cr | ₹0.36 Cr | ₹0.41 Cr |
Dividend Received | - | - | - | - | - |
Profit on sale of Fixed Assets | - | - | - | - | - |
Profits on sale of Investments | - | - | - | - | - |
Provision Written Back | - | - | - | - | - |
Foreign Exchange Gains | ₹13 Cr | ₹7.60 Cr | - | ₹11 Cr | - |
Others | ₹0.17 Cr | ₹0.32 Cr | ₹0.38 Cr | ₹0.40 Cr | ₹0.58 Cr |
Operating Profit | ₹671 Cr | ₹631 Cr | ₹592 Cr | ₹484 Cr | ₹248 Cr |
Interest | ₹0.55 Cr | ₹28 Cr | ₹88 Cr | ₹34 Cr | ₹0.61 Cr |
InterestonDebenture / Bonds | - | - | - | - | - |
Interest on Term Loan | - | - | - | - | - |
Intereston Fixed deposits | - | - | - | - | - |
Bank Charges etc | - | - | - | - | - |
Other Interest | ₹0.55 Cr | ₹28 Cr | ₹88 Cr | ₹34 Cr | ₹0.61 Cr |
PBDT | ₹671 Cr | ₹603 Cr | ₹504 Cr | ₹450 Cr | ₹248 Cr |
Depreciation | ₹42 Cr | ₹38 Cr | ₹33 Cr | ₹29 Cr | ₹19 Cr |
Profit Before Taxation & Exceptional Items | ₹629 Cr | ₹565 Cr | ₹471 Cr | ₹421 Cr | ₹228 Cr |
Exceptional Income / Expenses | - | - | - | - | - |
Profit Before Tax | ₹629 Cr | ₹565 Cr | ₹471 Cr | ₹421 Cr | ₹228 Cr |
Provision for Tax | ₹162 Cr | ₹146 Cr | ₹119 Cr | ₹108 Cr | ₹33 Cr |
Current Income Tax | ₹151 Cr | ₹138 Cr | ₹113 Cr | ₹99 Cr | ₹26 Cr |
Deferred Tax | ₹11 Cr | ₹8.57 Cr | ₹6.62 Cr | ₹7.17 Cr | ₹9.07 Cr |
Other taxes | - | - | - | ₹2.26 Cr | ₹-2.26 Cr |
Profit After Tax | ₹467 Cr | ₹419 Cr | ₹352 Cr | ₹313 Cr | ₹196 Cr |
Extra items | - | - | - | - | - |
Adjustments to PAT | - | - | - | - | - |
Profit Balance B/F | ₹1,021 Cr | ₹751 Cr | ₹400 Cr | ₹86 Cr | ₹-1.41 Cr |
Appropriations | ₹1,488 Cr | ₹1,170 Cr | ₹751 Cr | ₹399 Cr | ₹194 Cr |
General Reserves | - | - | - | - | - |
Proposed Equity Dividend | - | - | - | - | - |
Corporate dividend tax | - | - | - | - | - |
Other Appropriation | ₹129 Cr | ₹20 Cr | ₹0.53 Cr | ₹-0.47 Cr | ₹108 Cr |
Equity Dividend % | ₹1,050.00 | ₹1,050.00 | - | - | - |
Earnings Per Share | ₹38.11 | ₹34.17 | ₹358.76 | ₹1,597.44 | ₹997.92 |
Adjusted EPS | ₹38.11 | ₹34.17 | ₹32.61 | ₹29.04 | ₹18.14 |
Compare Income Statement of peers of GLENMARK LIFE SCIENCES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GLENMARK LIFE SCIENCES | ₹13,067.1 Cr | -1.6% | 2.6% | 74.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹422,271.0 Cr | -0.9% | -4.8% | 50.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹161,183.0 Cr | 3% | 5.9% | 65% | Stock Analytics | |
CIPLA | ₹120,605.0 Cr | 1.5% | 0.1% | 19.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹100,869.0 Cr | -0.4% | -8.2% | 7.1% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹95,808.6 Cr | 0.6% | -5.3% | 51% | Stock Analytics |
GLENMARK LIFE SCIENCES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GLENMARK LIFE SCIENCES | -1.6% |
2.6% |
74.8% |
SENSEX | 3.5% |
-0.1% |
21.9% |
You may also like the below Video Courses